Flagship Pioneering's Tessera Therapeutics plans to lay off 90 employees starting March 8, 2026. Gene editing biotech restructures despite $150M Regeneron investment for alpha-1 antitrypsin treatment.
Layoff News > Healthcare > Tessera Therapeutics
Tessera Therapeutics Layoffs 2026: 90 Jobs Cut in March
Published Dec 25, 2025
More From Layoff.Today
Other
LinkedIn Reduces Workforce by 5% Amid Strategic Reorganization
LinkedIn, owned by Microsoft, is laying off approximately 875 employees, or 5% of its global workforce, as part of a strategic reorganization to focus on
May 13, 2026
Retail
Walmart Restructures Corporate Teams, Affecting 1,000 Roles Amid AI Acceleration
Walmart is cutting or relocating approximately 1,000 corporate employees as part of a restructuring to streamline operations and align with AI-driven
May 13, 2026
Other
GitLab Announces Restructuring and Workforce Changes for AI Era
GitLab is undergoing a significant restructuring, including a voluntary separation window, as it pivots towards an AI-centric business model. The company
May 12, 2026
Hospitality
Topgolf Implements Layoffs Across U.S. Venues Amid Leadership Changes
Topgolf has reportedly laid off hundreds of employees across its U.S. venues, affecting sales, hospitality, operations, and management roles following a
May 12, 2026